Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NECAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UHRF1BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IFNA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100132735 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR11-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ART1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC5G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF3C6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMCHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on